Skip to main content
. 2023 Sep 7;29(4):356–363. doi: 10.1093/oncolo/oyad237

Figure 2.

Figure 2.

Top advantages and disadvantages of utilizing TM/RPM in clinical trials. (A) Respondents’ top 3 advantages of utilizing TM/RPM in clinical trials, ranked (n = 141). (B) Respondents’ top 3 disadvantages of utilizing TM/RPM in clinical trials, ranked (n = 141). (A) shows the percent frequencies that respondents chose advantages of using TM/RPM in clinical trials when listing their top 3 advantages. (B) shows the percent frequencies that respondents chose disadvantages of using TM/RPM in clinical trials when listing their top 3 disadvantages.